BRO vs GALT · P/E 30, rev $3.58B vs $142.4M cap
Brown & Brown Inc (BRO) versus Galectin Therapeutics Inc (GALT) — a side-by-side from cached financials, not a winner call.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Galectin Therapeutics Inc (GALT) is a biotechnology company listed on US.
Latest reported BRO revenue for 2026-06-30 was $3.58B. Net income was $714.0M. Revenue was up 88.2% from 2026-03-31 to 2026-06-30. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
GALT does not have a complete income-statement cache yet.
BRO currently screens at market cap $35.56B and trailing P/E 30.0. GALT currently screens at market cap $142.4M.
Not investment advice. Open the BRO and GALT stock pages for the full models.
Not investment advice.